Pfizer signals growth in FY 2025 with revenue forecast of $64 billionDecember 17, 2024 Pfizer forecasts 2025 revenue of up to $64 billion and adjusted earnings growth, navigating cost challenges amid Medicare changes and advancing promising drug pipeline assets, including its weight-loss candidate.
